Bcl-2 overexpression decreases BCNU sensitivity of a human glioblastoma line through enhancement of catalase activity
- 3 October 2001
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 83 (3) , 473-483
Abstract
The aim of this study was to evaluate the role of bcl‐2 in 1,3‐bis(2‐chloroethyl)‐1‐nitrosourea (BCNU) sensitivity of the ADFS human glioblastoma cell line in vitro and in vivo. To this end, the ADFS line expressing a low level of the bcl‐2 protein was transfected with a bcl‐2 expression vector. We found that bcl‐2 overexpressing clones were less sensitive to in vitro BCNU treatment than the control clone. Cell cycle analysis demonstrated that while BCNU induced a consistent block in S/G2‐M phases of the cell cycle in the control clone, it did not affect the cell cycle phase distribution of the two bcl‐2 transfectants. The different sensitivity to BCNU was unrelated to the ability of bcl‐2 to inhibit apoptosis, while bcl‐2 appeared to protect bcl‐2 transfectants from BCNU toxicity through an increase of catalase activity. The ability of the catalase inhibitor, sodium azide, to increase the BCNU sensitivity of the bcl‐2 transfectants to levels of the BCNU‐treated control clone substantiated the role of the catalase activity. The effect of bcl‐2 in reducing sensitivity to BCNU was also confirmed by in vivo experiments. Xenografts of bcl‐2 overexpressing tumors were less sensitive to BCNU treatment than xenografts originating from control cells. J. Cell. Biochem. 83: 473–483, 2001.Keywords
This publication has 21 references indexed in Scilit:
- Bax expressed from a herpes viral vector enhances the efficacy of N,N′-bis(2-hydroxyethyl)-N-nitrosourea treatment in a rat glioma modelCancer Gene Therapy, 2000
- Requirement for human AP endonuclease 1 for repair of 3′-blocking damage at DNA single-strand breaks induced by reactive oxygen speciesCarcinogenesis, 2000
- Pivotal Role of Reactive Oxygen Species as Intracellular Mediators of Hyperthermia-induced ApoptosisJournal of Biological Chemistry, 2000
- Interferon-α enhances CD95L-induced apoptosis of human malignant glioma cellsJournal of Neuroimmunology, 1998
- Unlocking the Blood–Brain Barrier: A Role for RMP-7 in Brain Tumor TherapyExperimental Neurology, 1996
- Shift of the Cellular Oxidation‐Reduction Potential in Neural Cells Expressing Bcl‐2Journal of Neurochemistry, 1996
- Lonidamine induces apoptosis in drug-resistant cells independently of the p53 gene.Journal of Clinical Investigation, 1996
- Regulation of cell division cycle progression by bcl-2 expression: a potential mechanism for inhibition of programmed cell death.Journal of Experimental Medicine, 1996
- Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation.Journal of Clinical Investigation, 1995
- Bcl-2 functions in an antioxidant pathway to prevent apoptosisCell, 1993